Literature DB >> 7679245

All MoMs are not equal: some statistical properties associated with reporting results in the form of multiples of the median.

J C Bishop1, F D Dunstan, B J Nix, T M Reynolds, A Swift.   

Abstract

The statistical procedure for discriminating between a Down syndrome or neural tube defect (NTD) fetus and a normal fetus relies, to a great extent, on the reporting of maternal serum alpha-fetoprotein (MSAFP), hCG, and uE3 results in the form of multiples of the median (MoMs). Further, threshold MoMs values for MSAFP, such as 2.5 MoMs, are often used to define a reference range to identify an NTD fetus. We show that a constant threshold-MoMs cutoff for MSAFP values actually refers to different percentiles of MSAFP levels at different gestational ages and that the combining of MoMs values between centers and gestational ages, such as suggested by Wald et al. for deriving a patient-specific risk index, is highly questionable. The results presented in this paper are quite general and will apply to all situations where MoMs are used.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 7679245      PMCID: PMC1682205     

Source DB:  PubMed          Journal:  Am J Hum Genet        ISSN: 0002-9297            Impact factor:   11.025


  3 in total

1.  Maternal serum alpha-fetoprotein (MSAFP) patient-specific risk reporting: its use and misuse.

Authors:  J N Macri; R V Kasturi; D A Krantz; E J Cook; J W Larsen
Journal:  Am J Hum Genet       Date:  1990-03       Impact factor: 11.025

2.  Influence of assay method differences on multiple of the median distributions: maternal serum alpha-fetoprotein as an example.

Authors:  C A Parvin; D L Gray; G Kessler
Journal:  Clin Chem       Date:  1991-05       Impact factor: 8.327

3.  Estimating a woman's risk of having a pregnancy associated with Down's syndrome using her age and serum alpha-fetoprotein level.

Authors:  H S Cuckle; N J Wald; S G Thompson
Journal:  Br J Obstet Gynaecol       Date:  1987-05
  3 in total
  7 in total

1.  Biochemistry on the human scale.

Authors:  Ken Sikaris
Journal:  Clin Biochem Rev       Date:  2010-11

2.  Is MoM bashing justified?

Authors:  G E Palomaki; G J Knight; J E Haddow
Journal:  Am J Hum Genet       Date:  1993-09       Impact factor: 11.025

Review 3.  Levels of soluble fms-like tyrosine kinase one in first trimester and outcomes of pregnancy: a systematic review.

Authors:  Marni Jacobs; Natasha Nassar; Christine L Roberts; Ruth Hadfield; Jonathan M Morris; Anthony W Ashton
Journal:  Reprod Biol Endocrinol       Date:  2011-06-08       Impact factor: 5.211

4.  Prediction of Gestational Diabetes Mellitus by Unconjugated Estriol Levels in Maternal Serum.

Authors:  Junguk Hur; Eun-Hee Cho; Kwang-Hyun Baek; Kyung Ju Lee
Journal:  Int J Med Sci       Date:  2017-02-07       Impact factor: 3.738

5.  First-trimester ultrasound measurements and maternal serum biomarkers as prognostic factors in monochorionic twins: a cohort study.

Authors:  Fiona L Mackie; Rebecca Whittle; R Katie Morris; Jon Hyett; Richard D Riley; Mark D Kilby
Journal:  Diagn Progn Res       Date:  2019-05-09

6.  Identification of Anti-Long Chain Saturated Fatty Acid IgG Antibodies in Serum of Patients with Type 2 Diabetes.

Authors:  Dequina A Nicholas; Lorena M Salto; Ava M Boston; Nan Sun Kim; Marco Larios; W Lawrence Beeson; Anthony F Firek; Carlos A Casiano; William H R Langridge; Zaida Cordero-MacIntyre; Marino De Leon
Journal:  Mediators Inflamm       Date:  2015-11-08       Impact factor: 4.711

7.  Evaluation of a Serum Lung Cancer Biomarker Panel.

Authors:  Peter J Mazzone; Xiao-Feng Wang; Xiaozhen Han; Humberto Choi; Meredith Seeley; Richard Scherer; Victoria Doseeva
Journal:  Biomark Insights       Date:  2018-01-15
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.